• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Bruce Kamich
    • Doug Kass
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • Trifecta Stocks
  1. Home
  2. / Investing
  3. / Healthcare

Rounding Up a Weak Quarter

U.S. stocks have been sluggish so far this year.
By CHRIS VERSACE AND LENORE HAWKINS Apr 01, 2015 | 02:00 PM EDT
Stocks quotes in this article: XLU, XLY, XLF, XLE, XLI, XLB, FXI, HEZU, IEV, MBLY, SWKS, FB, VXX, SH

Yesterday was the close of the first quarter, and so today we are taking stock of what last quarter delivered. The Dow Jones Industrial Average closed the quarter with a modest loss, the S&P 500 was basically flat, and the Nasdaq Composite Index and Russell 2000 had slight gains of 3.5% and 4% respectively. It was the weakest quarter for the S&P 500 since the fourth quarter of 2012, when the S&P 500 fell 1.27%.

 

From a sector performance perspective, health care took the lead thanks in part to the $95.3 billion in mergers and acquisitions announced during the quarter. The Health Care Select Sector SPDR (XLV) rose 6.03%. Consumer discretionary came in second with Consumer Discretionary Select Sector SPDR (XLY) up 4.44%.

Despite the arctic chill that gripped much of the country, the worst performers included utilities, an industry that in many ways is a proxy for bonds. It delivered the biggest loss, with Utilities Select Sector SPDR (XLU) down 5.91%. Financials were also down as the Financial Select Sector SPDR (XLF) fell 2.51%. Energy unsurprisingly took a beating, as well, with Energy Select Sector SPDR (XLE) down 2%. With the continued weaknesses in capital spending, we aren't surprised to see that Industrial Select Sector SPDR (XLI) fell 1.43%. Overall, only health care, consumer discretionary and real estate had any meaningful gains, with the remaining sectors relatively flat to negative.

Last quarter's sector performance is a major shift from the fourth quarter of 2014, when all sectors delivered strong positive performance, with the exceptions of Materials Select Sector SPDR (XLB), which fell 2.04%, and Energy Select Sector SPDR, which fell 12.6%. Utilities Select Sector SPDR was the highest performer in the fourth quarter, delivering a return of 12.19%, while in the first quarter, it was the worst performer, down almost 6%. In both the fourth and first quarters, consumer discretionary, real estate and health care delivered strong performances.

In comparison, stock markets outside the U.S. performed much better in the first quarter, with the German DAX delivering a whopping 22.5% and the French CAC 40 not far behind at 17.8%. Only the U.K. was near the U.S. with a meager 3.15% return. That was an impressive turnaround from the previous quarter when most all of these were in the red, with the exception of the German DAX, which was up a mere 3.5%, and the Nikkei 225, which was up 7.9%.

Looking forward to the rest of 2015, we are concerned with the trend in earnings expectations as revisions to estimates for S&P 500 earnings have been increasingly negative during the last three quarters, driven largely by the impact that the drop in oil prices has had on energy companies and the impact of a rising dollar on exporters. Exacerbating the situation is the current market valuation, which as we pointed out before is rather high when viewed against net income growth. Note we said net income growth not earnings-per-share growth, which is receiving a helping hand from the massive buybacks we've highlighted to you here. The chart below shows how expectations for 2015 earnings have gone from slightly positive -- with the exception of the fourth quarter of 2015 -- to strongly negative in each quarter starting in June of last year. By now, earnings for all four quarters of 2015 are expected to be below the previous period's earnings, which is consistent with the continued stream of weaker-than-expected economic news. That brings us to another reason to be more alert than usual this Friday. We wouldn't be surprised to see a few public companies quietly slipping in unflattering earnings warnings for the first quarter with most of Wall Street away.

On Monday, we learned that the Chicago Purchasing Manager Index for March came in at 46.3, almost as bad as the horrible number in February and well below expectations for 51.7 from last month's glum 45.8. With two straight lower readings, there is cause for concern. According to a report by research firm Bespoke, there have been 17 prior streaks where the Chicago PMI was below 50 for at least two months in a row, and all but four started or ended within a year before or after a recession.

In contrast, this morning we learned that the Markit Eurozone Manufacturing PMI hit a 10-month high of 52.2 in March, up from 51 in February with growth accelerating in Germany, Spain, Italy and the Netherland and companies raising employment at the fastest pace in over three-and-a-half years. The European economy and stock markets are benefiting from lower oil prices, the effects of a weaker euro versus the dollar and the "whatever it takes" policies from the European Central Bank.

By comparison, the latest and not so greatest PMI data for China reversed gears in March after a modest improvement in February. That reinforces the notion of stringing several months of data together so as not to get head-faked by any one data point. New order growth tumbled, and we see that as meaningful for the short-term direction of the economy, particularly because the "Chinese New Year" excuse can't be used in March. We continue to think China will eventually ratchet up its own stimulative efforts, and so we like iShares FTSE/Xinhua China 25 Index (FXI).

Putting it all together, we think that European stocks will likely outperform U.S. stocks and that the dollar has further room to strengthen with the Fed's promised rate rise and the ECB's commitment to quantitative easing. We can see why investors rushed into exchange-traded funds such as iShares Currency Hedged MSCI EMU (HEZU), and we continue to favor iShares Europe (IEV). For those investors preferring to stick with U.S. stocks, our recommendation is to be cautious in the near term and favor companies that have momentum such as Mobileye (MBLY), Skyworks Solutions (SWKS) and Facebook (FB).

With current U.S. valuations, global tensions from Ukraine to Greece and likely earnings disappointments, investors might consider putting on a little protection with an ETF such as iPath S&P 500 VIX Short-Term Future ETN (VXX) or ProShares Short S&P 500 (SH). If you instead see the glass half full, build that stock shopping list so that you're prepared should any of your favorites go on "on sale" in the next few weeks.

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

Lenore Hawkins and Chris Versace have no positions in securities mentioned, but the Thematic Growth Portfolio managed by Versace owns FB, IEV, MBLY, SH and SWKS shares.

TAGS: Investing | U.S. Equity | Healthcare | Markets | Stocks

More from Healthcare

Boston Scientific Could Be Wicked Good in This Kind of Market

Brad Ginesin
May 24, 2022 2:13 PM EDT

Here's why this healthcare stock is a potential port in the storm for investors.

2 Biotech Stocks to Own as M&A Potentially Gathers Steam

Bret Jensen
May 11, 2022 11:35 AM EDT

I like these names as stand-alone entities but they should also attract interest from larger players.

China Faces 'Tsunami' of Covid Infection That Could Swamp the System

Alex Frew McMillan
May 11, 2022 9:00 AM EDT

A new study suggests 1.55 million people could die if China abandons zero-Covid, with the intensive-care system needing 15.6 times existing capacity.

I'm Giving Dynavax Another Shot -- a Booster Shot

Bret Jensen
May 8, 2022 7:31 AM EDT

Despite an earnings miss, DVAX show promise in several vaccine fronts and I'm doubling down on the name.

In This Environment, I'd Be More Risk Averse With Intuitive Surgical

Stephen Guilfoyle
Apr 25, 2022 10:50 AM EDT

The firm has been hurt and continues to be hurt by the effects of the pandemic.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 10:58 AM EDT JAMES "REV SHARK" DEPORRE

    This Weekend on Real Money

    "The Tremendous Power of the Sell Button"
  • 02:46 PM EDT STEPHEN GUILFOYLE

    We're Shedding Some of This Holding on Strength

    Check out the Stocks Under $10 portfolio here!
  • 11:33 AM EDT PETER TCHIR

    Thoughts Ahead of the Fed Minutes

    Recent economic and earnings issues are convincing...
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2022 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login